Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug 7:2:17.
doi: 10.1186/1755-8166-2-17.

Microdeletion of 6q16.1 encompassing EPHA7 in a child with mild neurological abnormalities and dysmorphic features: case report

Affiliations

Microdeletion of 6q16.1 encompassing EPHA7 in a child with mild neurological abnormalities and dysmorphic features: case report

Ryan N Traylor et al. Mol Cytogenet. .

Abstract

Background: Of the fewer than 100 cases reported within the literature of constitutional deletions involving the long arm of chromosome 6, only five have been characterized using high-resolution microarray analysis. Reported 6q deletion patients show a high incidence of mental retardation, ear anomalies, hypotonia, and postnatal growth retardation.

Results: We report a 16-month-old male presenting with developmental delay and dysmorphic features who was found by array-based comparative genomic hybridization (aCGH) to have a ~2.16 Mb de novo deletion within chromosome band 6q16.1 that encompasses only two genes. Expression studies of the mouse homologue of one of the genes, the ephrin receptor 7 gene (EPHA7), have shown the gene functions during murine embryogenesis to form cortical domains, determine brain size and shape, and play a role in development of the central nervous system (CNS).

Discussion: Our results suggest that deletion of EPHA7 plays a role in the neurologic and dysmorphic features, including developmental delay, hypotonia, and ear malformations, observed in some 6q deletion patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proband at age 15 months. Note triangular-shaped face, mild ptosis on the left side, and cupped, posteriorly rotated ears.
Figure 2
Figure 2
Brain MRI showing (A) possible brain atrophy and possible hemorrhage, (B) slight thinning of the corpus collosum posteriorly and (C) decrease in white matter volume seen posteriorly in the cerebral hemispheres bilaterally.
Figure 3
Figure 3
Analysis of deletion encompassing EPHA7 on 6q16.1. (A) Oligonucleotide microarray plot showing a copy-number loss of 30 oligo probes spanning 2.16 Mb at 6q16.1 (chr6:92,836,995–94,905,920). Probes are ordered on the x-axis according to physical mapping positions with distal 6p to the left and distal 6q to the right. (B) FISH demonstrating deletion of EPHA7. BAC clone RP11-270O11 which encompasses EPHA7 was labeled in red and the centromere probe to chromosome 6 (D6Z1) was labeled in green as a control. One red signal was present, indicating deletion of EPHA7.
Figure 4
Figure 4
Zoomed view of 6q15-6q21. Blue bars represent minimal deletion sizes; black lines represent maximum deletion sizes for each patient based on gaps in microarray coverage. Bar A is the current case with a deletion size of 2.1 Mb. Bar B is Klein et al. [2] patient 2 with a deletion size of 6–16.2 Mb; Bar C is Klein et al. [2] patient 1 with deletion of size 8.8–16.4 Mb; Bar D is Klein et al. [2] patient 3 with deletion size of 11.3–15.7 Mb; Bar E is the patient presented by Le Caignec et al. [4] with deletion size of 12.9–15.7 Mb; Bar F is the patient presented by Zherebstov et al. [3] with deletion size of 34 Mb (the bar image for this deletion extends beyond the coordinates depicted). The dark blue band represents EPHA7.

Similar articles

Cited by

  • Homozygous deletion of Tenascin-R in a patient with intellectual disability.
    Dufresne D, Hamdan FF, Rosenfeld JA, Torchia B, Rosenblatt B, Michaud JL, Srour M. Dufresne D, et al. J Med Genet. 2012 Jul;49(7):451-4. doi: 10.1136/jmedgenet-2012-100831. Epub 2012 Jun 22. J Med Genet. 2012. PMID: 22730557 Free PMC article.
  • Molecular and clinical delineation of the 17q22 microdeletion phenotype.
    Laurell T, Lundin J, Anderlid BM, Gorski JL, Grigelioniene G, Knight SJ, Krepischi AC, Nordenskjöld A, Price SM, Rosenberg C, Turnpenny PD, Vianna-Morgante AM, Nordgren A. Laurell T, et al. Eur J Hum Genet. 2013 Oct;21(10):1085-92. doi: 10.1038/ejhg.2012.306. Epub 2013 Jan 30. Eur J Hum Genet. 2013. PMID: 23361222 Free PMC article.
  • Recurrent HERV-H-mediated 3q13.2-q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delays.
    Shuvarikov A, Campbell IM, Dittwald P, Neill NJ, Bialer MG, Moore C, Wheeler PG, Wallace SE, Hannibal MC, Murray MF, Giovanni MA, Terespolsky D, Sodhi S, Cassina M, Viskochil D, Moghaddam B, Herman K, Brown CW, Beck CR, Gambin A, Cheung SW, Patel A, Lamb AN, Shaffer LG, Ellison JW, Ravnan JB, Stankiewicz P, Rosenfeld JA. Shuvarikov A, et al. Hum Mutat. 2013 Oct;34(10):1415-23. doi: 10.1002/humu.22384. Epub 2013 Aug 13. Hum Mutat. 2013. PMID: 23878096 Free PMC article.
  • Refinement of the Region for Split Hand/Foot Malformation 5 on 2q31.1.
    Theisen A, Rosenfeld JA, Shane K, McBride KL, Atkin JF, Gaba C, Hoo J, Kurczynski TW, Schnur RE, Coffey LB, Zackai EH, Schimmenti L, Friedman N, Zabukovec M, Ball S, Pagon R, Lucas A, Brasington CK, Spence JE, Sparks S, Banks V, Smith W, Friedberg T, Wyatt PR, Aust M, Tervo R, Crowley A, Skidmore D, Lamb AN, Ravnan B, Sahoo T, Schultz R, Torchia BS, Sgro M, Chitayat D, Shaffer LG. Theisen A, et al. Mol Syndromol. 2010;1(5):262-271. doi: 10.1159/000328405. Epub 2011 May 18. Mol Syndromol. 2010. PMID: 22140379 Free PMC article.
  • Haploinsufficiency of SOX5 at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic features.
    Lamb AN, Rosenfeld JA, Neill NJ, Talkowski ME, Blumenthal I, Girirajan S, Keelean-Fuller D, Fan Z, Pouncey J, Stevens C, Mackay-Loder L, Terespolsky D, Bader PI, Rosenbaum K, Vallee SE, Moeschler JB, Ladda R, Sell S, Martin J, Ryan S, Jones MC, Moran R, Shealy A, Madan-Khetarpal S, McConnell J, Surti U, Delahaye A, Heron-Longe B, Pipiras E, Benzacken B, Passemard S, Verloes A, Isidor B, Le Caignec C, Glew GM, Opheim KE, Descartes M, Eichler EE, Morton CC, Gusella JF, Schultz RA, Ballif BC, Shaffer LG. Lamb AN, et al. Hum Mutat. 2012 Apr;33(4):728-40. doi: 10.1002/humu.22037. Hum Mutat. 2012. PMID: 22290657 Free PMC article.

References

    1. Hopkin RJ, Schorry E, Bofinger M, Milatovich A, Stern HJ, Jayne C, Saal HM. New insights into the phenotypes of 6q deletions. Am J Med Genet. 1997;70:377–386. doi: 10.1002/(SICI)1096-8628(19970627)70:4<377::AID-AJMG9>3.0.CO;2-Q. - DOI - PubMed
    1. Klein OD, Cotter PD, Moore MW, Zanko A, Gilats M, Epstein CJ, Conte F, Rauen KA. Interstitial deletions of chromosome 6q: genotype-phenotype correlation utilizing array CGH. Clin Genet. 2007;71:260–266. doi: 10.1111/j.1399-0004.2007.00757.x. - DOI - PubMed
    1. Zherebtsov MM, Klein RT, Aviv H, Toruner GA, Hanna NN, Brooks SS. Further delineation of interstitial chromosome 6 deletion syndrome and review of the literature. Clin Dysmorphol. 2007;16:135–140. doi: 10.1097/MCD.0b013e3281e668d5. - DOI - PubMed
    1. Le Caignec C, Swillen A, Van Asche E, Fryns JP, Vermeesch JR. Interstitial 6q deletion: clinical and array CGH characterisation of a new patient. Eur J Med Genet. 2005;48:339–345. doi: 10.1016/j.ejmg.2005.04.010. - DOI - PubMed
    1. Bonaglia MC, Ciccone R, Gimelli G, Gimelli S, Marelli S, Verheij J, Giorda R, Grasso R, Borgatti R, Pagone F, et al. Detailed phenotype-genotype study in five patients with chromosome 6q16 deletion: narrowing the critical region for Prader-Willi-like phenotype. Eur J Hum Genet. 2008;16:1443–1449. doi: 10.1038/ejhg.2008.119. - DOI - PubMed

LinkOut - more resources